PHARMACOLOGICAL COMPARISON OF THE RAT AND GUINEA-PIG CORTICAL HIGH-AFFINITY 5-HYDROXYTRYPTAMINE UPTAKE SYSTEM

被引:8
作者
HORNSBY, CD
BARNES, JM
BARNES, NM
CHAMPANERIA, S
COSTALL, B
NAYLOR, RJ
机构
[1] UNIV BIRMINGHAM,SCH MED,DEPT PHARMACOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] UNIV BRADFORD,SCH PHARM,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
关键词
D O I
10.1016/0006-2952(92)90723-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacological characteristics of the high affinity [H-3]5-hydroxytryptamine ([H-3]5-HT) uptake system were investigated in the cerebral cortex of the rat and guinea-pig. In crude cortical synaptosomal preparations from the rat and guinea-pig, [H-3]5-HT accumulated with high affinity (K(m), 72 +/- 12 and 57 +/- 14 nM for rat and guinea-pig cortical synaptosomal preparation, respectively, mean +/- SEM, N = 5) and with a comparable maximum activity (V(max), 1.22 +/- 0.21 and 0.90 +/- 0.19 pmol/min/mg protein for rat and guinea-pig cortical synaptosomal preparation, respectively, mean +/- SEM, N = 5). Competition studies employing a range of structurally diverse competing compounds showed that the [H-3]5-HT uptake was pharmacologically similar in both preparations. However, citalopram possessed approximately 10-fold weaker affinity to prevent [H-3]5-HT uptake in the guinea-pig preparation when compared to the rat and all of the tricyclic antidepressants assessed in the present studies (amitriptyline. nortriptyline, desipramine and imipramine) displayed higher affinity in the guinea-pig preparation when compared to the rat. It is concluded that the high affinity 5-HT uptake systems in the rat and guinea-pig cortex are similar but may not be identical.
引用
收藏
页码:1865 / 1868
页数:4
相关论文
共 18 条
[1]   BEHAVIORAL PHARMACOLOGY OF 5-HT3-RECEPTOR LIGANDS [J].
BARNES, JM ;
BARNES, NM ;
COOPER, SJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) :107-113
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   EFFECT OF SOME ANORECTIC AGENTS ON UPTAKE AND RELEASE OF 5-HYDROXYTRYPTAMINE BY BLOOD-PLATELETS OF RATS [J].
BUCZKO, W ;
GAETANO, GD ;
GARATTINI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (05) :366-368
[4]   THE PHARMACOLOGICAL CHARACTERIZATION OF 5-HT3 RECEPTORS IN 3 ISOLATED PREPARATIONS DERIVED FROM GUINEA-PIG TISSUES [J].
BUTLER, A ;
ELSWOOD, CJ ;
BURRIDGE, J ;
IRELAND, SJ ;
BUNCE, KT ;
KILPATRICK, GJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :591-598
[5]  
Fuller R.W., 1988, ADV DRUG RES, V17, P349
[6]   SEROTONIN RECEPTORS - CLINICAL IMPLICATIONS [J].
GLENNON, RA .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (01) :35-47
[7]   BEHAVIORAL PROPERTIES OF GBR-12909, GBR-13069 AND GBR-13098 - SPECIFIC INHIBITORS OF DOPAMINE UPTAKE [J].
HEIKKILA, RE ;
MANZINO, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 103 (3-4) :241-248
[8]   STUDIES ON CAPACITY OF MAZINDOL AND DITA TO ACT AS UPTAKE INHIBITORS OR RELEASING AGENTS FOR H-3-BIOGENIC AMINES IN RAT-BRAIN TISSUE-SLICES [J].
HEIKKILA, RE ;
CABBAT, FS ;
MYTILINEOU, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 45 (04) :329-333
[9]  
HORNSBY C D, 1990, British Journal of Pharmacology, V100, p396P
[10]   SPECIES-DIFFERENCES IN THE PHARMACOLOGY OF TERMINAL 5-HT AUTORECEPTORS IN MAMMALIAN BRAIN [J].
HOYER, D ;
MIDDLEMISS, DN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (04) :130-132